M. Weingert

The HOPE (Heart Outcomes Prevention Evaluation) Study: the design of a large, simple randomized trial of an angiotensin-converting enzyme inhibitor (ramipril) and vitamin E in patients at high risk of cardiovascular events. The HOPE study investigators.

Janzen, A. M. Møller, D. Debanne, 1996, The Canadian journal of cardiology.

Unnecessary diuretic therapy in the elderly.

C. Gryfe, R. Fisher, M. Myers, 1982, Age and ageing.

The LONGevity & Type 1 Diabetes Macrovascular Epidemiology (LONGTIME) Study: Carotid Intima Media Thickness, LV Strain and Endothelial Dysfunction in Type 1 Diabetes of 50 Years Duration

I. Hramiak, S. Harris, J. Mahon, 2016 .

The effect of digoxin on mortality and morbidity in patients with heart failure.

E. J. Brown, Hack, D. M. Barr, 1997, The New England journal of medicine.

Rationale, design, implementation, and baseline characteristics of patients in the DIG trial: a large, simple, long-term trial to evaluate the effect of digitalis on mortality in heart failure.

D. M. Barr, D. F. Hughes, R. Collins, 1996, Controlled clinical trials.

Cardiac sequelae of acute stroke.

V. Hachinski, M. Sole, J. Norris, 1982, Stroke.